Advanced search
Publication Cover
Journal of Investigative Surgery Volume 31, 2018 - Issue 2
Submit an article Journal homepage
2,008
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization

Liang-Yong LiDepartment of Neurology, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, China
,
Huai-Zhen ChenDepartment of Neurology, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, China
,
Yuan-Cheng BaoDepartment of Neurology, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, China
,
Qing-Sheng YuDepartment of General Surgery, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, China
&
Wen-Ming YangDepartment of Neurology, the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, ChinaCorrespondence[email protected]
Pages 75-81 | Received 17 Nov 2016, Accepted 27 Dec 2016, Published online: 31 Jan 2017

References

  • Loudianos G, et al. Wilson's disease. Prilozi 2014;35(1):93–98.
  • Pfeiffer RF. Wilson's Disease. Semin Neurol. 2007;27(2): 123–132.
  • Harada M. Pathogenesis and management of Wilson disease. Hepatol Res. 2014.
  • Brewer GJ. Novel therapeutic approaches to the treatment of Wilson's disease. Expert Opin Pharmacother. 2006;7(3):317–324.
  • Amin MA, et al. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33(8):1702–1710.
  • Zhu K et al. Partial splenic embolization for hypersplenism in cirrhosis: A long-term outcome in 62 patients. Dig Liver Dis. 2009;41(6):411–416.
  • Sternlieb I, Scheinberg IH, and Walshe JM. Bleeding oesophageal varices in patients with Wilson's disease. Lancet 1970;1(7648):638–641.
  • Abdella HM, et al. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia. Indian J Gastroenterol. 2010;29(2):59–61.
  • Alzen G, et al. Partial splenic embolization as an alternative to splenectomy in hypersplenism–single center experience in 16 years. Klin Padiatr. 2010;222(6):368–373.
  • Yoshida H, et al. Partial splenic embolization. Hepatol Res. 2008;38(3):225–233.
  • Madoff DC, et al. Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 2005;25(Suppl 1):S191–S211.
  • Koconis KG, Singh H, and Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: A review of the English language literature. J Vasc Interv Radiol. 2007;18(4):463–481.
  • Murata K, et al. Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology 2008;55(85):1407–1411.
  • Smith M, Ray C.E. Splenic artery embolization as an adjunctive procedure for portal hypertension. Semin Intervent Radiol. 2012;29(2):135–139.
  • Tokgoz O, et al. Infraclavicular brachial plexus block in Wilson's disease. Middle East J Anesthesiol. 2013;22(1):103–106.
  • Baykal M, Karapolat S. Anesthetic management of a pediatric patient with wilsons disease. J Clin Med Res. 2010;2(2):99–101.
  • Bo W, et al. Laparoscopy splenectomy for massive splenomegaly. J Invest Surg. 2013;26(3):154–157.
  • Gu JJ, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiol. 2012;53(8):862–867.
  • Kim B, Chung SJ, and Shin HW. Trientine-induced neurological deterioration in a patient with Wilson's disease. J Clin Neurosci. 2013;20(4):606–608.
  • Kim YE, et al. Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson's disease. BMC Neurol. 2013;13:127.
  • Kalita J, et al. Worsening of Wilson disease following penicillamine therapy. Eur Neurol. 2014;71(3,4):126–31.
  • Lang CJ, et al. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Arch Neurol. 1993;50(10):1007–1008.
  • Choi BS, Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14–21.
  • Monnot AD, et al. Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency. Toxicol Appl Pharmacol. 2011;256(3): 249–257.
  • Stuerenburg HJ. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm. 2000;107(3):321–329.
  • Li WJ, Wang JF, Wang XP. Wilson's disease: update on integrated Chinese and Western medicine. Chin J Integr Med. 2013;19(3): 233–240.
  • Aggarwal A, Bhatt M. Update on Wilson disease. Int Rev Neurobiol. 2013;110:313–348.
  • Dalvi A, Padmanaban M. Wilson's disease: etiology, diagnosis, and treatment. Dis Mon. 2014;60(9):450–459.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.